United States Protein Chips Market By Technology (Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays), By Application (Diagnostics, Proteomics, Antibody Characterization, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes, Others), By Region, Competition Forecast & Opportunities, 2027

United States protein chips market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of increasing applications of protein analysis and detection of the protein with their specific functions. Demand for personalized medicine and genetic medicine further drive the growth of the United States protein chips market in the upcoming five years.

Protein chips are technologically advanced method of protein detection and analysis of the protein functions. The methods help in understanding the protein expressions, and protein activity. Such analysis of protein helps in better understanding of the diseases, viral infection causing severe infectious diseases, pharmaceutical development, etc. The protein chip surface consists of nitrocellulose membrane, microtiter plate, glass slip, and bead.

These chips are also known as protein microarray, that are cost efficient, automated, advanced technology and have higher efficiency in terms of analyzing even the trace amount of reagents or samples. Some of the major applications of the protein chips involve antibody characterizations, protein function analysis, proteomics, diagnosis purposes.

Personalized Medicine Demands Drive Market Growth

Rapidly growing demand for the personalized medicine and genetic medicine are actively driving the growth of the United States protein chips market in the upcoming five years. With advancement in the healthcare sector and pharmaceutical industry, technological achievements in the protein analysis overcomes the drawbacks of DNA microarrays. Protein expressions with the use of protein chips allows the gene expression to the level of its translation into protein molecule, structure analysis and thus functionality of the respective gene.

Furthermore, increasing instances of chronic diseases like cancer that often has the tendency to relocate its core multiply, requires more personalized medicine for its symptom reductions. Cancer cases in the United States have been multiplying rapidly.

253,465 cases of breast cancer, 227, 875 cases of lung cancer, 209,512 cases of prostate cancer, 101,809 cases of colorectum cancer, 96,445 cases of melanoma, 80,617 cases of urinary bladder cancer, and 42,284 cases of cancer

Government Support Aids Market Growth

The government of the United States has a detailed and well-structured healthcare sector development team. Increasing investments and favorable schemes from the government are also supporting the growth of the United Sates protein chips market in the next five years.

2021, the United States Research & Development expenses were USD597.26 billion

The use of protein chips is an advancement over the utilization of the common methods like DNA microarrays, chromatography, etc. Technology like reverse phase protein microarrays further allows the detailed and specific phosphorylated, cleaved, or total forms of cellular proteins be it phosphorylated or non

Click here to download the sample

Market Segmentation

The United States protein chips market is segmented by technology, application, end user, competitional landscape, and regional distribution.

Based on technology, the market is further differentiated into analytical microarrays, functional protein microarrays, and reverse phase protein microarrays. On the basis of application, the market segment is bifurcated into diagnostics, proteomics, antibody characterization, and others.

Market segments on the basis of end user, is further fragmented into hospitals & clinics, diagnostic laboratories, academic & research institutes, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among North-East region, Mid-West region, West region, South region.

Company Profile

Illumina Inc., Thermo Fischer Scientific, Inc., PerkinElmer, Inc., Danaher Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Raybiotech Inc., Arrayit Corporation